HIV Cure Advances Prompt Warnings on Benefits Cliff for 300,000 Long-Term Survivors

The STAT piece highlights that the Ryan White HIV/AIDS Program served over 600,000 people in 2024, more than half of diagnosed U.S. cases. Long-term survivors diagnosed before 1996 ART availability now number roughly 300,000, many with multimorbidity, trauma, and employment gaps from early toxic regimens. A narrow focus on viral status risks reclassifying need during routine Medicaid or housing reviews even when disability remains unchanged. Timothy Ray Brown’s post-cure housing difficulties illustrate the gap between biological remission and restored economic security. Similar patterns appear in hepatitis C cure cohorts where SVR did not automatically restore disability determinations. Current policy lacks explicit carve-outs linking continued eligibility to documented sequelae rather than HIV diagnosis alone. Analyses from CDC surveillance and HRSA Ryan White reports show nearly half of people with HIV are now 50 or older, amplifying the scale of potential administrative churn. Without prospective safeguards, cure announcements could accelerate disenrollment before longitudinal data on functional recovery exist. Next steps require HHS guidance defining medical necessity beyond viral load and pilot studies tracking post-cure service utilization.